| abstract |
The present invention relates to the supply of coenzyme Q, which is very useful for maintaining human health, and to provide a method and agent for effectively supplying coenzyme Q to patients who have difficulty in oral administration, elderly who are difficult to swallow, and patients with diseases caused by local diseases. It is. Improved by the use of a composition for transmucosal administration containing coenzyme Q and / or reduced coenzyme Q as an active ingredient in blood or topical mucosa, wherein the total amount of oxidized coenzyme Q and reduced coenzyme Q is determined by the total composition weight. 0.0001 to 99% by weight. |